Market Cap 598.34M
Revenue (ttm) 687.80M
Net Income (ttm) -392.10M
EPS (ttm) N/A
PE Ratio 11.90
Forward PE 11.90
Profit Margin -57.01%
Debt to Equity Ratio 0.13
Volume 587,100
Avg Vol 554,750
Day's Range N/A - N/A
Shares Out 46.42M
Stochastic %K 90%
Beta 1.08
Analysts Hold
Price Target $14.00

Company Profile

Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready co...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 428 2667
Website: avanos.com
Address:
5405 Windward Parkway, Suite 100 South, Alpharetta, United States
ZacksResearch
ZacksResearch Jan. 29 at 7:01 PM
Hold onto $AVNS — the bull case is still alive 📈 AVNS is showing solid 3Q25 momentum, driven by SNS and PMR growth, with M&A and cost cuts supporting results even as tariffs and FX volatility linger. See why AVNS still earns a spot in your portfolio 👉 https://www.zacks.com/stock/news/2825619/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2825619-teaser-31086&ADID=SYND_STOCKTWITS_TWEET_2_2825619_TEASER_31086
0 · Reply
ZacksResearch
ZacksResearch Jan. 29 at 6:01 PM
$AVNS up 10.1% in 6 months compared to the industry's 5.2% growth — what's driving the growth? 🚀 📈 Specialty Nutrition Systems & Pain Management segments show strong double-digit growth 🤝 Strategic M&A and portfolio optimization are expected to boost revenue and EPS ⚙️ Cost optimization initiatives targeting $15-$20M in annual savings by 2026 Discover the growth factors and challenges here 👉 https://www.zacks.com/stock/news/2825619/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2825619-body-31087&ADID=SYND_STOCKTWITS_TWEET_2_2825619_BODY_31087
0 · Reply
JohnTill
JohnTill Jan. 21 at 3:16 PM
$AVNS Still rocking and 6 month high. Chart looks like a breakout but do not want to leave 30% profits on the table so just locked in a few more and now riding a "free" position. The tariff news is such a binary event I would rather not have my neck too far out.
0 · Reply
JohnTill
JohnTill Jan. 14 at 8:55 PM
$AVNS Well that worked out quick. Locked in a few above 11.90 just in case the tariff news take a while and gets my base cost down to 10. My only big concern is on the last conference call they mentioned a big China write-off coming so keeping my position down going into earnings but want that tariff pop.
0 · Reply
JohnTill
JohnTill Jan. 13 at 6:32 PM
$AVNS Added a bunch more today at 11.58 on the almost touch of the 50MA to bring the avg. to 11.10 on a very decent position. If tariffs are reversed this adds $4+ overnight and if they are not reversed the current plan appears solid for a steady upturn in 2026-27 - win/win. Chart looks like it wants to go lower so waiting to add in the short term but that longer term chart sure looks like a wedge waiting to break to the upside with measured move $3-4 higher. Does the market already know something? HELE is the other that will add huge from here is tariffs are overturned.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 6:13 PM
$AVNS RSI: 52.56, MACD: 0.1001 Vol: 0.33, MA20: 11.61, MA50: 11.50 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 9 at 10:45 PM
$AVNS Share Price: $11.39 Contract Selected: Jul 17, 2026 $12.5 Calls Buy Zone: $0.96 – $1.18 Target Zone: $1.65 – $2.02 Potential Upside: 63% ROI Time to Expiration: 219 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Estimize
Estimize Nov. 26 at 11:00 AM
Wall St is expecting 0.25 EPS for $AVNS Q4 [Reporting 02/24 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 10 at 7:54 PM
$AVNS Share Price: $11.36 Contract Selected: Apr 17, 2026 $10 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.34 Potential Upside: 55% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
d_risk
d_risk Nov. 5 at 9:41 PM
$AVNS - Avanos Medical Inc. Common Stock - 10Q - Updated Risk Factors AVNS flags new risks from recent US tariffs, possible USMCA/WTO withdrawal, and global retaliation impacting supply chains, plus warns that cuts to third-party healthcare reimbursements could materially hurt business. #MedicalDevices #GlobalTradeUncertainty #TradeTariffs #SupplyChainRisk #HealthcareReimbursement 🟢 Added 🟠 Removed https://d-risk.ai/AVNS/10-Q/2025-11-05
0 · Reply
Latest News on AVNS
Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 4:41 PM EST - 3 months ago

Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript


Avanos Medical, Inc. Announces Third Quarter 2025 Results

Nov 5, 2025, 7:00 AM EST - 3 months ago

Avanos Medical, Inc. Announces Third Quarter 2025 Results


The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice

Aug 29, 2025, 10:00 AM EDT - 5 months ago

The Bottom Fishing Club - Avanos Medical: Bargain Defensive Choice


Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 1:26 PM EDT - 6 months ago

Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call Transcript


Avanos Medical, Inc. Announces Second Quarter 2025 Results

Aug 5, 2025, 6:30 AM EDT - 6 months ago

Avanos Medical, Inc. Announces Second Quarter 2025 Results


Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript

May 6, 2025, 2:38 PM EDT - 9 months ago

Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript


Avanos Medical, Inc. Announces First Quarter 2025 Results

May 6, 2025, 7:00 AM EDT - 9 months ago

Avanos Medical, Inc. Announces First Quarter 2025 Results


Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 12:41 PM EST - 1 year ago

Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript


Avanos Medical Launches New CORGRIP® SR

Nov 5, 2024, 7:00 AM EST - 1 year ago

Avanos Medical Launches New CORGRIP® SR


Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript

Oct 30, 2024, 3:28 PM EDT - 1 year ago

Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript


Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 1:35 PM EDT - 1 year ago

Avanos Medical, Inc. (AVNS) Q2 2024 Earnings Call Transcript


Avanos Medical, Inc. Announces Second Quarter 2024 Results

Jul 31, 2024, 7:00 AM EDT - 1 year ago

Avanos Medical, Inc. Announces Second Quarter 2024 Results


Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript

May 5, 2024, 8:37 AM EDT - 1 year ago

Avanos Medical, Inc. (AVNS) Q1 2024 Earnings Call Transcript


Avanos Medical, Inc. Announces First Quarter 2024 Results

May 2, 2024, 7:00 AM EDT - 1 year ago

Avanos Medical, Inc. Announces First Quarter 2024 Results


Avanos Medical, Inc. (AVNS) Q4 2023 Earnings Call Transcript

Feb 20, 2024, 11:07 AM EST - 2 years ago

Avanos Medical, Inc. (AVNS) Q4 2023 Earnings Call Transcript


ZacksResearch
ZacksResearch Jan. 29 at 7:01 PM
Hold onto $AVNS — the bull case is still alive 📈 AVNS is showing solid 3Q25 momentum, driven by SNS and PMR growth, with M&A and cost cuts supporting results even as tariffs and FX volatility linger. See why AVNS still earns a spot in your portfolio 👉 https://www.zacks.com/stock/news/2825619/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2825619-teaser-31086&ADID=SYND_STOCKTWITS_TWEET_2_2825619_TEASER_31086
0 · Reply
ZacksResearch
ZacksResearch Jan. 29 at 6:01 PM
$AVNS up 10.1% in 6 months compared to the industry's 5.2% growth — what's driving the growth? 🚀 📈 Specialty Nutrition Systems & Pain Management segments show strong double-digit growth 🤝 Strategic M&A and portfolio optimization are expected to boost revenue and EPS ⚙️ Cost optimization initiatives targeting $15-$20M in annual savings by 2026 Discover the growth factors and challenges here 👉 https://www.zacks.com/stock/news/2825619/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2825619-body-31087&ADID=SYND_STOCKTWITS_TWEET_2_2825619_BODY_31087
0 · Reply
JohnTill
JohnTill Jan. 21 at 3:16 PM
$AVNS Still rocking and 6 month high. Chart looks like a breakout but do not want to leave 30% profits on the table so just locked in a few more and now riding a "free" position. The tariff news is such a binary event I would rather not have my neck too far out.
0 · Reply
JohnTill
JohnTill Jan. 14 at 8:55 PM
$AVNS Well that worked out quick. Locked in a few above 11.90 just in case the tariff news take a while and gets my base cost down to 10. My only big concern is on the last conference call they mentioned a big China write-off coming so keeping my position down going into earnings but want that tariff pop.
0 · Reply
JohnTill
JohnTill Jan. 13 at 6:32 PM
$AVNS Added a bunch more today at 11.58 on the almost touch of the 50MA to bring the avg. to 11.10 on a very decent position. If tariffs are reversed this adds $4+ overnight and if they are not reversed the current plan appears solid for a steady upturn in 2026-27 - win/win. Chart looks like it wants to go lower so waiting to add in the short term but that longer term chart sure looks like a wedge waiting to break to the upside with measured move $3-4 higher. Does the market already know something? HELE is the other that will add huge from here is tariffs are overturned.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 6:13 PM
$AVNS RSI: 52.56, MACD: 0.1001 Vol: 0.33, MA20: 11.61, MA50: 11.50 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
SuperGreenToday
SuperGreenToday Dec. 9 at 10:45 PM
$AVNS Share Price: $11.39 Contract Selected: Jul 17, 2026 $12.5 Calls Buy Zone: $0.96 – $1.18 Target Zone: $1.65 – $2.02 Potential Upside: 63% ROI Time to Expiration: 219 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Estimize
Estimize Nov. 26 at 11:00 AM
Wall St is expecting 0.25 EPS for $AVNS Q4 [Reporting 02/24 BMO] http://www.estimize.com/intro/avns?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 10 at 7:54 PM
$AVNS Share Price: $11.36 Contract Selected: Apr 17, 2026 $10 Calls Buy Zone: $0.17 – $0.21 Target Zone: $0.28 – $0.34 Potential Upside: 55% ROI Time to Expiration: 157 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
d_risk
d_risk Nov. 5 at 9:41 PM
$AVNS - Avanos Medical Inc. Common Stock - 10Q - Updated Risk Factors AVNS flags new risks from recent US tariffs, possible USMCA/WTO withdrawal, and global retaliation impacting supply chains, plus warns that cuts to third-party healthcare reimbursements could materially hurt business. #MedicalDevices #GlobalTradeUncertainty #TradeTariffs #SupplyChainRisk #HealthcareReimbursement 🟢 Added 🟠 Removed https://d-risk.ai/AVNS/10-Q/2025-11-05
0 · Reply
mwb1
mwb1 Oct. 31 at 3:20 PM
0 · Reply
ZacksResearch
ZacksResearch Sep. 18 at 12:59 PM
$AVNS making moves in critical care with a new acquisition! Avanos just acquired Nexus Medical, adding cutting-edge TKO anti-reflux technology to its portfolio. This deal is expected to be immediately accretive to revenues and earnings, potentially boosting the stock in the near term. See what this means for AVNS’s growth trajectory 👉 https://www.zacks.com/stock/news/2753225/avanos-medical-buys-nexus-medical-to-bolster-critical-care-portfolio?cid=sm-stocktwits-2-2753225-body-12975&ADID=SYND_STOCKTWITS_TWEET_2_2753225_BODY_12975
0 · Reply
ZacksResearch
ZacksResearch Sep. 18 at 11:59 AM
$AVNS making moves — this acquisition could be a game-changer. By adding Nexus Medical and its TKO connector, the company instantly expands its critical care portfolio while driving immediate revenue and earnings growth. Full breakdown of the deal here 👉 https://www.zacks.com/stock/news/2753225/avanos-medical-buys-nexus-medical-to-bolster-critical-care-portfolio?cid=sm-stocktwits-2-2753225-teaser-12974&ADID=SYND_STOCKTWITS_TWEET_2_2753225_TEASER_12974
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 5:13 PM
$AVNS dropped 22.4% YTD — what's happening? 🩺 Despite strong Q2 product performance and strategic transformation efforts, tariff risks and FX volatility are pressing hard on margins. ⚠️ Understand the risks before investing in AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-body-11833&ADID=SYND_STOCKTWITS_TWEET_2_2749660_BODY_11833
0 · Reply
ZacksResearch
ZacksResearch Sep. 10 at 4:13 PM
$AVNS showing why it deserves a spot in portfolios right now. Solid Q2 results, strong product demand, and ongoing strategic transformation are fueling growth even with tariff and FX headwinds. See the full case for holding AVNS 👉 https://www.zacks.com/stock/news/2749660/reasons-to-retain-avanos-medical-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2749660-teaser-11830&ADID=SYND_STOCKTWITS_TWEET_2_2749660_TEASER_11830
0 · Reply
NVDAMillionaire
NVDAMillionaire Sep. 10 at 10:44 AM
$AVNS Outstanding article that hits the mark on AVNS's current state. So if you want to refresh your AVNS insights or learn about AVNS from scratch, this is a must read. https://beyondspx.com/quote/AVNS/analysis/avanos-medical-precision-focus-and-innovation-fueling-a-targeted-transformation-nyse-avns
0 · Reply
SignalMap
SignalMap Aug. 23 at 6:26 AM
$AVNS Avanos Medical Inc is a medical device company facing product portfolio transition and margin challenges
0 · Reply
ManosDeDiamante07
ManosDeDiamante07 Aug. 17 at 2:08 AM
$AVNS Get ready and be patient
0 · Reply
SocioCobb
SocioCobb Aug. 15 at 5:14 PM
$AVNS Insider purchase tag 👀
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 6:17 PM
$AVNS drops 12.1% after mixed Q2 results — what's going on? 📉 ⚠️ EPS down 50% YoY & adjusted EPS miss by 5.6% 📈 Total revenue up 1.9% YoY, beating estimates 📉 Margin contraction & tariff costs weigh on profitability Understand the risks before investing in Avanos 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-body-6476&ADID=SYND_STOCKTWITS_TWEET_2_2674143_BODY_6476
0 · Reply
ZacksResearch
ZacksResearch Aug. 6 at 5:06 PM
$AVNS drops hard on Q2 miss — but is the worst priced in? Earnings missed estimates, margins contracted, and tariff headwinds hit profitability — shares sank 12% on the news. Full breakdown here 👉 https://www.zacks.com/stock/news/2674143/avanos-medical-stock-down-as-q2-earnings-miss-estimates-margins-down?cid=sm-stocktwits-2-2674143-teaser-6424&ADID=SYND_STOCKTWITS_TWEET_2_2674143_TEASER_6424
0 · Reply